OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MLTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLTX is expected to report earnings to fall 2.38% to -84 cents per share on November 18

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q3'25

Est.

$-0.85

Q2'25

Missed

by $0.15

Q1'25

Beat

by $0.13

Q4'24

Missed

by $0.12

Q3'24

Missed

by $0.12

The last earnings report on August 05 showed earnings per share of -87 cents, missing the estimate of -72 cents. With 44.05K shares outstanding, the current market capitalization sits at 3.33B.

View a ticker or compare two or three

Compare

MLTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MLTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLTX showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Dorfstrasse 29

Phone

+41 415108022

Employees

Web

https://www.moonlaketx.com